e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
The emergence of drug-resistant tuberculosis in Europe: no cure possible?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Management of patients with M/XDR-tuberculosis in Europe
Christoph Lange (Borstel, Germany)
Source:
International Congress 2015 – The emergence of drug-resistant tuberculosis in Europe: no cure possible?
Session:
The emergence of drug-resistant tuberculosis in Europe: no cure possible?
Session type:
Symposium
Number:
244
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Christoph Lange (Borstel, Germany). Management of patients with M/XDR-tuberculosis in Europe. International Congress 2015 – The emergence of drug-resistant tuberculosis in Europe: no cure possible?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Tuberculosis management in Europe
Source: Guideline 1999
Year: 1999
Evaluation of respiratory symptoms in COPD patients from seven Latin America countries: The LASSYC Study
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
Pharmacotherapy of COPD in Central and Eastern Europe - The POPE study
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Treatment outcomes of new TB cases among children in Russia
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Respiratory manifestation of HIV/AIDS patients in Iran
Source: Eur Respir J 2005; 26: Suppl. 49, 642s
Year: 2005
Treatment of multimorbid asthma patients in structured care. Results from the Disease Management Program (DMP) Bronchial Asthma in the North Rhine region in Germany.
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018
Management of childhood pneumonia in ambulatory patients in Macedonia
Source: Annual Congress 2008 - Miscellaneous respiratory infections
Year: 2008
Drug resistance and HIV rates are high in Eastern European patients with Tuberculosis in a South East London Hospital
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
First analysis of the Severe Paediatric Asthma Collaborative in Europe registry
Source: ERJ Open Res, 6 (4) 00566-2020; 10.1183/23120541.00566-2020
Year: 2020
Prevalence of chronic bronchitis in the Middle-East and North Africa: Interim results of the BREATHE study
Source: Annual Congress 2011 - Respiratory epidemiology: prevalence, incidence and remission
Year: 2011
Severe Paediatric Asthma Collaborative in Europe (SPACE): protocol for a European registry
Source: Breathe, 14 (2) 93; 10.1183/20734735.002018
Year: 2018
The burden of asthma in Canadian children and adolescents of South Asian descent
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013
Asthma ICs prescriptions in primary care in France and the United Kingdom: Are they similar?
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
Measuring guideline adherence for the diagnosis and management of common cold and pneumonia in rural Gambia. A case for a Clinical Decision Support System in rural sub-Sarahan Africa?
Source: International Congress 2019 – Treatment of airway diseases in primary care
Year: 2019
Underestimation of pediatric asthma in Belarus, Poland, and Ukraine
Source: International Congress 2014 – Epidemiology of asthma
Year: 2014
Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study
Source: Eur Respir J, 49 (5) 1601446; 10.1183/13993003.01446-2016
Year: 2017
A cross-sectional study in severe COPD patients in the Middle East and Africa (MEA): Methodology and patients’ profile
Source: International Congress 2018 – COPD around the world
Year: 2018
Bronchiectasis among hospitalised patients in Germany
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Treatment effectiveness of TB patients from different groups of population in Moscow
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Evaluation of asthma control among children in the Maghreb and sub-SaharIan Africa
Source: International Congress 2016 – Living with asthma around the globe
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept